TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 12439162

Group type: EXPERIMENTAL
Intervention: Low-dose dexamethasone (0.51 mg/kg)
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: High-dose dexamethasone (1.41 mg/kg)
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control (placebo)
Number of subjects: 49
Study: 10363221

Group type: EXPERIMENTAL
Intervention: Safer Choices program
Number of subjects: 3677
Study: 8624226

Group type: EXPERIMENTAL
Intervention: Triclosan/copolymer pre-brush mouthrinse (0.03% triclosan and 0.13% PVM/MA copolymer)
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo pre-brush mouthrinse
Number of subjects: 121
Study: 2140489

Group type: EXPERIMENTAL
Intervention: Nicorandil 60 mg
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Nicorandil 40 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Nicorandil 10 mg
Number of subjects: 25

Group type: COMPARATOR
Intervention: Nicorandil 20 mg
Number of subjects: 25
Study: 415330

Group type: EXPERIMENTAL
Intervention: 0.75 ml/kg of 95% ethanol
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 8 mg of delta9 tetrahydrocannabinol (THC)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 15 mg of delta9 tetrahydrocannabinol (THC)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: 0.75 ml/kg of 95% ethanol together with 15 mg of THC
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31072317

Group type: EXPERIMENTAL
Intervention: Eye Movement Dual Task (EMDT) in combination with usual care
Number of subjects: 90

Group type: COMPARATOR
Intervention: Usual care alone
Number of subjects: 90
Study: 28125809

Group type: EXPERIMENTAL
Intervention: AmF/NaF/SnCl2 solution twice a day
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: AmF/NaF/SnCl2 solution once a day
Number of subjects: 12

Group type: COMPARATOR
Intervention: NaF solution (positive control, 500 ppm F‐, pH 4.5)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Deionized water (negative control)
Number of subjects: 12
Study: 25501988

Group type: EXPERIMENTAL
Intervention: Efavirenz 400 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Efavirenz 600 mg
Number of subjects: 28

Group type: EXPERIMENTAL
Intervention: Efavirenz 400 mg and 600 mg
Number of subjects: 28
Study: 22505131

Group type: EXPERIMENTAL
Intervention: PNF stretching (2 minutes, 4 sets of 5-second isometric hamstring contraction followed by 5 seconds of passive static stretch of the quadriceps and 5 seconds isometric quadriceps contraction)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Control session (walking at a comfortable speed for 2 minutes)
Number of subjects: 12
Study: 21875913

Group type: EXPERIMENTAL
Intervention: High-dose clopidogrel for 6 months
Number of subjects: 2800

Group type: EXPERIMENTAL
Intervention: OTR <208 P2Y12 reaction units
Number of subjects: 2800

Group type: EXPERIMENTAL
Intervention: OTR <208 P2Y12 reaction units (adjusted)
Number of subjects: 2800
Study: 19905900

Group type: EXPERIMENTAL
Intervention: Participants in the Stockholm trial
Number of subjects: 115

Group type: COMPARATOR
Intervention: Non-participants in the Stockholm trial
Number of subjects: 115
Study: 17023769

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine (loading dose 1 microg/kg in 10 minutes followed by an infusion rate of 0.2 microg/kg/hr)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 40

Group type: COMPARATOR
Intervention: Saline (control group)
Number of subjects: 40
Study: 14615470

Group type: EXPERIMENTAL
Intervention: HMR1031 under fasted conditions
Number of subjects: 8

Group type: COMPARATOR
Intervention: HMR1031 under fed conditions
Number of subjects: 8
Study: 11127250

Group type: EXPERIMENTAL
Intervention: Paromomycin (PM) 12 mg/kg daily plus Sodium Stibogluconate (SB) 20 mg/kg daily for 21 days
Number of subjects: 150

Group type: EXPERIMENTAL
Intervention: Paromomycin (PM) 18 mg/kg daily plus Sodium Stibogluconate (SB) 20 mg/kg daily for 21 days
Number of subjects: 150

Group type: COMPARATOR
Intervention: Sodium Stibogluconate (SB) alone for 30 days
Number of subjects: 150
Study: 9263282

Group type: EXPERIMENTAL
Intervention: Glutamine supplementation
Number of subjects: 84

Group type: COMPARATOR
Intervention: Isonitrogenous, isoenergetic control
Number of subjects: 84
Study: 8474811

Group type: EXPERIMENTAL
Intervention: Iron-fortified formula with 12.7 mg/L iron
Number of subjects: 347

Group type: EXPERIMENTAL
Intervention: Iron-fortified formula with 7.4 mg/L iron
Number of subjects: 347

Group type: COMPARATOR
Intervention: Breast-fed group
Number of subjects: 347
Study: 3082347

Group type: EXPERIMENTAL
Intervention: 2 mg SCG aerosol
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 10 mg SCG aerosol
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: 20 mg SCG aerosol
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11

Group type: EXPERIMENTAL
Intervention: Nebulised SCG (10 g l‐1)
Number of subjects: 11
Study: 30467952

Group type: EXPERIMENTAL
Intervention: Mildly increased uACR (≥10 mg/g <30 mg/g)
Number of subjects: 2176

Group type: EXPERIMENTAL
Intervention: Mildly increased uACR (≥10 mg/g <30 mg/g) in nonwhites
Number of subjects: 2176
Study: 28464496

Group type: EXPERIMENTAL
Intervention: Pibrentasvir
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Pibrentasvir with ritonavir
Number of subjects: 0
Study: 27284115

Group type: EXPERIMENTAL
Intervention: Cognitive remediation therapy using the frontal/executive program for about six months
Number of subjects: 15

Group type: EXPERIMENTAL
Intervention: Cognitive remediation therapy using the frontal/executive program
Number of subjects: 15

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 15
Study: 24493413

Group type: EXPERIMENTAL
Intervention: Delayed (123)I-MIBG scintigraphy
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Flow-mediated dilation (FMD)
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Combination of delayed (123)I-MIBG scintigraphy and FMD
Number of subjects: 78

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 78
Study: 22535754

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with virgin olive oil (MD-VOO)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Mediterranean diet supplemented with mixed nuts (MD-Nuts)
Number of subjects: 516

Group type: COMPARATOR
Intervention: Low-fat diet (LFD)
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Mediterranean diet (MD) groups
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Highest tertile of virgin olive oil and vegetable consumption
Number of subjects: 516

Group type: EXPERIMENTAL
Intervention: Changes in consumption of virgin olive oil and vegetables
Number of subjects: 516
Study: 20493957

Group type: EXPERIMENTAL
Intervention: Doxycycline (100mg, twice daily)
Number of subjects: 379

Group type: EXPERIMENTAL
Intervention: Doxycycline
Number of subjects: 379

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 379
Study: 16784344

Group type: EXPERIMENTAL
Intervention: Identity expression via in-group bias on symbolic measures in stable, high-status groups
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Material in-group bias for instrumental motives in unstable, low-status groups when communicating with in-group members
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Extreme forms of in-group bias for instrumental reasons in stable, low-status groups
Number of subjects: 0
Study: 14745756

Group type: EXPERIMENTAL
Intervention: Air-distention
Number of subjects: 50

Group type: COMPARATOR
Intervention: Water-distention
Number of subjects: 50
Study: 11756577

Group type: EXPERIMENTAL
Intervention: Intravenous immune globulin
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study: 9433634

Group type: EXPERIMENTAL
Intervention: Proband dependent (PD) sampling procedures
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Nonsingle ascertainment
Number of subjects: 0
Study: 8345160

Group type: EXPERIMENTAL
Intervention: Alprazolam
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Imipramine
Number of subjects: 55

Group type: EXPERIMENTAL
Intervention: Alprazolam or Imipramine
Number of subjects: 55
Study: 3104386

Group type: EXPERIMENTAL
Intervention: Free medical care (no cost-sharing)
Number of subjects: 5765

Group type: COMPARATOR
Intervention: Cost-sharing insurance plans
Number of subjects: 5765
Study: 30286704

Group type: EXPERIMENTAL
Intervention: Low-frequency electrical stimulation (LFES) during half-time recovery
Number of subjects: 22

Group type: COMPARATOR
Intervention: Placebo group
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: Low-frequency electrical stimulation (LFES)
Number of subjects: 22
Study: 29772839

Group type: EXPERIMENTAL
Intervention: Active Schools: Skelmersdale (AS:Sk) intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (normal practice)
Number of subjects: 0
Study: 27317093

Group type: EXPERIMENTAL
Intervention: febuxostat (10-60 mg/day)
Number of subjects: 500

Group type: COMPARATOR
Intervention: non-pharmacological treatment
Number of subjects: 500
Study: 25457732

Group type: EXPERIMENTAL
Intervention: Multicomponent school-based nutrition education intervention over 1 academic year
Number of subjects: 490

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 490
Study: 22147281

Group type: EXPERIMENTAL
Intervention: Behaviour-change intervention
Number of subjects: 802

Group type: COMPARATOR
Intervention: Control group (comparison area)
Number of subjects: 802
Study: 20206354

Group type: EXPERIMENTAL
Intervention: 200mg of oral mifepristone followed 2 days later by 400 microg of sublingual misoprostol
Number of subjects: 199
Study: 18823488

Group type: EXPERIMENTAL
Intervention: SurePath liquid-based cytology (LBC)
Number of subjects: 913

Group type: COMPARATOR
Intervention: Conventional smear cytology
Number of subjects: 913
Study: 17873260

Group type: EXPERIMENTAL
Intervention: Individualized decision aid (DA)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: DA + Coaching (DA + CC)
Number of subjects: 145

Group type: COMPARATOR
Intervention: Control group (generic educational materials)
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: DA
Number of subjects: 145

Group type: EXPERIMENTAL
Intervention: DA + CC
Number of subjects: 145
Study: 12483405

Group type: EXPERIMENTAL
Intervention: Technetium-99m ethyl cysteinate dimer SPET
Number of subjects: 140
Study: 10952840

Group type: COMPARATOR
Intervention: Unfractionated heparin (bolus of 5000 IU followed by an infusion of 1200 IU.h(‐1))
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Low-dose hirudin (0.2 mg.kg(‐1) bolus followed by 0.10 mg.kg(‐1).h(‐1))
Number of subjects: 395

Group type: EXPERIMENTAL
Intervention: Medium-dose hirudin (0.4 mg.kg(‐1) bolus followed by 0.15 mg.kg(‐1).h(‐1))
Number of subjects: 395
Study: 9062836

Group type: EXPERIMENTAL
Intervention: 6-hour food deprivation (FD)
Number of subjects: 32

Group type: COMPARATOR
Intervention: No food deprivation (NFD)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High restrained eating (HR)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Moderate restrained eating (MR)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Low restrained eating (LR)
Number of subjects: 32
Study: 8393055

Group type: EXPERIMENTAL
Intervention: Ganciclovir prophylaxis (group 1)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Acyclovir prophylaxis (group 2)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Acyclovir prophylaxis and ganciclovir treatment (group 3)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Prophylaxis and treatment with ganciclovir (group 4)
Number of subjects: 42
Study: 3088298

Group type: EXPERIMENTAL
Intervention: Combination therapy using carmofur (HCFU), mitomycin C (MMC) and immunopotentiators (group B)
Number of subjects: 166

Group type: COMPARATOR
Intervention: Mitomycin C (MMC) and immunopotentiators (group A)
Number of subjects: 166
Study: 30360679

Group type: EXPERIMENTAL
Intervention: semi‐immersive virtual reality training with BTS‐N
Number of subjects: 20

Group type: COMPARATOR
Intervention: traditional cognitive training
Number of subjects: 20
Study: 27450552

Group type: EXPERIMENTAL
Intervention: 5 mg folate supplements
Number of subjects: 60
Study: 24581069

Group type: EXPERIMENTAL
Intervention: Experimental nicotine vaccine
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 49
Study: 23574058

Group type: EXPERIMENTAL
Intervention: Prediction-based method
Number of subjects: 966

Group type: COMPARATOR
Intervention: Opinion-based method
Number of subjects: 966
Study: 21067660

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS), 200 micrograms, single dose
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Mometasone furoate nasal spray (MFNS), 200 micrograms, for 6 days
Number of subjects: 155

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 155
Study: 18976982

Group type: EXPERIMENTAL
Intervention: Active magnetic knee wrap (n=24)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Sham magnetic knee wrap (n=26)
Number of subjects: 50
Study: 16769377

Group type: EXPERIMENTAL
Intervention: Indomethacin prophylaxis
Number of subjects: 999

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 999
Study: 12806909

Group type: EXPERIMENTAL
Intervention: Listening group
Number of subjects: 30

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Performance group
Number of subjects: 30
Study: 10674617

Group type: EXPERIMENTAL
Intervention: IGF‐I/BP‐3 complex (1 to 4 mg/kg/day for 5 days)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Saline (control)
Number of subjects: 22
Study: 8970458

Group type: EXPERIMENTAL
Intervention: 2 mg dihydroergotamine mesylate
Number of subjects: 310

Group type: EXPERIMENTAL
Intervention: 3 mg dihydroergotamine mesylate
Number of subjects: 310

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 310
Study: 1310110

Group type: EXPERIMENTAL
Intervention: High fiber, low fat diet
Number of subjects: 42

Group type: COMPARATOR
Intervention: Low fiber, high fat diet
Number of subjects: 42
Study: 6382172

Group type: EXPERIMENTAL
Intervention: Cognitive strategy - sensory transformation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Other cognitive-behavioral pain-coping strategies
Number of subjects: 100
Study: 30726533

Group type: EXPERIMENTAL
Intervention: Ortataxel 75 mg/m2 i.v. every 3 weeks until disease progression
Number of subjects: 40
Study: 28370614

Group type: EXPERIMENTAL
Intervention: High-dose concurrent chemoradiotherapy (CRT)
Number of subjects: 7219

Group type: COMPARATOR
Intervention: Low-dose concurrent chemoradiotherapy (CRT)
Number of subjects: 7219
Study: 26503069

Group type: EXPERIMENTAL
Intervention: GoFAR
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: FACELAND
Number of subjects: 30

Group type: COMPARATOR
Intervention: CONTROL
Number of subjects: 30
Study: 22682958

Group type: EXPERIMENTAL
Intervention: Electrical stimulation of the hearing organ (n=58 tinnitus ears)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Electrical stimulation together with cervical spine kinesitherapy (n=61 tinnitus ears)
Number of subjects: 80
Study: 21496851

Group type: EXPERIMENTAL
Intervention: 18-core biopsy
Number of subjects: 150

Group type: COMPARATOR
Intervention: 12-core biopsy
Number of subjects: 150
Study: 19121921

Group type: EXPERIMENTAL
Intervention: Regulat (fermented food concentrate) taken twice daily for 4 weeks
Number of subjects: 48

Group type: COMPARATOR
Intervention: Placebo (essence of vinegar)
Number of subjects: 48
Study: 16822812

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent
Number of subjects: 20

Group type: COMPARATOR
Intervention: Bare metal stent
Number of subjects: 20
Study: 14702153

Group type: EXPERIMENTAL
Intervention: lopinavir/ritonavir plus stavudine and lamivudine
Number of subjects: 653

Group type: COMPARATOR
Intervention: nelfinavir plus stavudine and lamivudine
Number of subjects: 653
Study: 11373691

Group type: EXPERIMENTAL
Intervention: 192Ir
Number of subjects: 55

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 55
Study: 9259399

Group type: EXPERIMENTAL
Intervention: Tamoxifen (TAM) 20 mg/day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: ICI 182780 (ICI) 6 or 18 mg/day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Non-treatment (NT) control group
Number of subjects: 0
Study: 8503668

Group type: EXPERIMENTAL
Intervention: Shuang Huang Lian herbs
Number of subjects: 96

Group type: EXPERIMENTAL
Intervention: Shuang Huang Lian herbs with antibiotics
Number of subjects: 96

Group type: COMPARATOR
Intervention: Antibiotics alone
Number of subjects: 96
Study: 2966694

Group type: EXPERIMENTAL
Intervention: Aspirin
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: Naloxone
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 31092152

Group type: EXPERIMENTAL
Intervention: ticagrelor
Number of subjects: 13199

Group type: COMPARATOR
Intervention: aspirin
Number of subjects: 13199
Study: 28566194

Group type: EXPERIMENTAL
Intervention: Active tVNS
Number of subjects: 13

Group type: COMPARATOR
Intervention: Sham-T
Number of subjects: 13

Group type: COMPARATOR
Intervention: tLS
Number of subjects: 13
Study: 26202097

Group type: EXPERIMENTAL
Intervention: Intensive blood pressure management (target systolic BP <140 mm Hg)
Number of subjects: 2794

Group type: COMPARATOR
Intervention: Guideline-based blood pressure management (target systolic BP <180 mm Hg)
Number of subjects: 2794
Study: 23294485

Group type: EXPERIMENTAL
Intervention: IORT alone
Number of subjects: 230

Group type: COMPARATOR
Intervention: IORT‐EBRT
Number of subjects: 230
Study: 21480098

Group type: EXPERIMENTAL
Intervention: Tone-emitting otoscope
Number of subjects: 2251

Group type: EXPERIMENTAL
Intervention: Hearing handicap questionnaire
Number of subjects: 2251

Group type: EXPERIMENTAL
Intervention: Both screening strategies together
Number of subjects: 2251

Group type: COMPARATOR
Intervention: No screening (control group)
Number of subjects: 2251
Study: 19412676

Group type: EXPERIMENTAL
Intervention: Mediterranean diet with nuts
Number of subjects: 106

Group type: EXPERIMENTAL
Intervention: Mediterranean diet with virgin olive oil (VOO)
Number of subjects: 106

Group type: COMPARATOR
Intervention: Low-fat diet
Number of subjects: 106
Study: 16322886

Group type: EXPERIMENTAL
Intervention: Instruction video seen
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Palpation aid used
Number of subjects: 100

Group type: COMPARATOR
Intervention: Instruction video not seen
Number of subjects: 100

Group type: COMPARATOR
Intervention: Palpation aid not used
Number of subjects: 100
Study: 15320644

Group type: EXPERIMENTAL
Intervention: Full range of motion training (Group 1: N = 11)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Partial range of motion training (Group 2: N = 15)
Number of subjects: 56

Group type: EXPERIMENTAL
Intervention: Combination of partial and full range of motion training (Group 3: N = 30)
Number of subjects: 56

Group type: COMPARATOR
Intervention: Partial range of motion training
Number of subjects: 56
Study: 11918129

Group type: EXPERIMENTAL
Intervention: Loprinone hydrochloride (0.3 pg/kg/min)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 9631203

Group type: EXPERIMENTAL
Intervention: Thermal detection distractor
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Light detection distractor
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Neutral imagining distractor
Number of subjects: 50

Group type: COMPARATOR
Intervention: No distraction
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Imagining an enjoyable holiday
Number of subjects: 50
Study: 7712736

Group type: EXPERIMENTAL
Intervention: Graft reactions in patients with reported symptoms (redness, sensitivity to light, loss of vision, pain)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Scheduled examinations in the first postoperative year
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Reports of red eye and vision loss
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Severity of reaction
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Age of patients
Number of subjects: 456
Study: 2503295

Group type: EXPERIMENTAL
Intervention: Oral contraceptives containing 50 ug of ethinyl estradiol combined with 250 mg levonorgestrel
Number of subjects: 680

Group type: EXPERIMENTAL
Intervention: Oral contraceptives containing 30 ug of ethinyl estradiol combined with 250 mg levonorgestrel
Number of subjects: 680

Group type: COMPARATOR
Intervention: Both interventions (50 ug and 30 ug ethinyl estradiol)
Number of subjects: 680
Study: 797410

Group type: EXPERIMENTAL
Intervention: fenoterol (400 mug)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: SCH 1000 (40 mug)
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: fenoterol (400 mug) and SCH 1000 (40 mug) combination
Number of subjects: 20
Study: 31290017

Group type: EXPERIMENTAL
Intervention: Enamel matrix derivative (EMD)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Control (without EMD)
Number of subjects: 40
Study: 30793687

Group type: EXPERIMENTAL
Intervention: Community-led total sanitation program
Number of subjects: 1170
Study: 27787464

Group type: COMPARATOR
Intervention: 2-second eccentric contractions
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 4-second eccentric contractions
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: 6-second eccentric contractions
Number of subjects: 30
Study: 26419668

Group type: EXPERIMENTAL
Intervention: Dapaconazole tosylate 2% cream
Number of subjects: 60

Group type: COMPARATOR
Intervention: Ketoconazole 2% cream
Number of subjects: 60
Study: 23793133

Group type: EXPERIMENTAL
Intervention: Green tea (4.5 g green tea/330 ml, providing approximately 400 mg catechins)
Number of subjects: 43

Group type: COMPARATOR
Intervention: Water (330 ml)
Number of subjects: 43
Study: 19117287

Group type: EXPERIMENTAL
Intervention: Intracapsular microdebridement
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Intracapsular coblation
Number of subjects: 156

Group type: COMPARATOR
Intervention: Traditional extracapsular electrocautery
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Comparison of all three techniques
Number of subjects: 156

Group type: EXPERIMENTAL
Intervention: Microdebrider
Number of subjects: 156
Study: 17483857

Group type: EXPERIMENTAL
Intervention: Group Psychoeducation (GPE) - 4 sessions delivered during hospital admission
Number of subjects: 48

Group type: COMPARATOR
Intervention: No sessions of GPE with usual care
Number of subjects: 48
Study: 15451390

Group type: EXPERIMENTAL
Intervention: SGS742 (600 mg t.i.d. for 8 weeks)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 110
Study: 11819837

Group type: EXPERIMENTAL
Intervention: Intraluminal stent installation combined with intra-arterial drug infusion
Number of subjects: 281

Group type: COMPARATOR
Intervention: Intraluminal stent installation only (control group)
Number of subjects: 281